<DOC>
	<DOCNO>NCT02812953</DOCNO>
	<brief_summary>A sample plasma whole blood obtain 3 time point ( pre-procedural , early post-procedural hospital discharge ) . Test platelet reactivity ( LTA , light transmittance aggregometry Elisa PRI , Platelet reactivity index ) multimeric VWF ( von Willebrand factor ) analyse performed time blood sample . Aliquots plasma store frozen analysis</brief_summary>
	<brief_title>Biological Collection Registry Patients Who Will Have TAVR ( Transcatheter Aortic Valve Replacement ) Intervention</brief_title>
	<detailed_description>There two major objective : - To correlate change VWF platelet reactivity TAVR clinical outcome - To correlate change VWF platelet reactivity antithrombotic regimen TAVR ( direct anticoagulant apixaban versus standard care , ie Vitamin K antagonist antiplatelet therapy ) .</detailed_description>
	<criteria>patient undergo TAVR intervention agreement give severe thrombopenia ( &lt; 40.10^9/L )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>